RHHBY.PK |

Mike Havrilla

ImmunoCellular's Promising Brain Cancer Vaccine
on Oct 28, 2009 • AGEN, CLDX, EXEL
ImmunoCellular: What's Next After Roche Deal?
on Sep 14, 2009 • IMUC.OB, RHHBY.PK
ImmunoCellular: Roche Pact Validates Pipeline Potential
on Sep 09, 2009 • IMUC.OB, RHHBY.PK
Small Cap Stocks Battling Brain Cancer
on Sep 07, 2009 • ARKTF.PK, BMY, CLDX
FDA Calendar Updates: Achillion Pharma, Roche, Genzyme, Protalix, Shire
on Jul 31, 2009 • ACHN, GENZ, PLX
FDA Calendar Updates: United Therapeutics, Roche
on Jul 30, 2009 • RHHBY.PK, UTHR
Access Pharma: Deep Pipeline, Shallow Valuation
on Jul 15, 2009 • ACCP.OB, AEZS, ALTH
FDA Calendar Updates: BioMarin, OSI, Roche, Abraxis, Johnson & Johnson
on Jul 14, 2009 • ABII, BMRN, JNJ
FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO
on Jun 01, 2009 • ALTH, AZN, BVTI.PK
Access Pharma: A Smallcap Cancer Biotech Call Option Trade
on May 28, 2009 • ACCP.OB, CGRB, CTIC
FDA, Clinical Trial Updates: Biogen, Roche, Salix, Cell Therapeutics, Pfizer
on May 20, 2009 • BIIB, CTIC, PFE
Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches
on May 18, 2009 • ALTH, AMGN, CRGN
FDA Calendar Updates: Acorda, Roche
on May 07, 2009 • ACOR, RHHBY.PK
FDA, Clinical Trial Calendar Updates: Genzyme, Isis, Osiris, Roche, Watson
on Apr 23, 2009 • GENZ, ISIS, OSIR
Opportunities in Healthcare: Highly Defensive Stocks
on Apr 14, 2009 • ABT, ABV, AMGN
FDA and Clinical Trial Updates: Weight Loss, Diabetes and More
on Apr 02, 2009 • ACOR, ARNA, AZN
FDA and Clinical Trial Updates: Osiris Sees Flaw in Crohn's Disease Trial
on Mar 29, 2009 • DYAX, OSIR, RHHBY.PK
FDA and Clinical Trial Calendars: Favorable Vote for Sanofi's Multaq
on Mar 22, 2009 • BAYRY.PK, JNJ, OSIP
Cytori Therapeutics: Natural Play on Cosmetic Medicine
on Mar 02, 2009 • CYTX, GE, GERN
New Index of Highly Defensive Market Cap Leaders
on Feb 26, 2009 • ABT, ABX, AMGN
Bio-Pharma, Diagnostics Buyout Binge Begins
on Jan 11, 2009 • ADLS, BDSI, BMY
1H09 Catalysts for 4 Healthcare Stocks
on Jan 08, 2009 • DSCO, MELA, NSPH
Stem Cell and Regenerative Medicine Stocks Surge in December
on Dec 20, 2008 • ABMD, ATSI, CYTX
Weekly FDA Calendar Update
on Dec 07, 2008 • ADLS, AGN, AZN
Regenerative Medicine: Big Pharma's Next Frontier
on Nov 19, 2008 • ASTM, BMTI, CRY
Market Update: Roche/Genentech Deal, AstraZeneca's New Statin, Yahoo, Microsoft Deal?
on Nov 10, 2008 • AZN, DGX, DNA
Expanding the Defensive Growth Index Into Europe
on Oct 23, 2008 • ACL, BAX, BTI
A Defensive Growth Stock Index
on Oct 21, 2008 • AHBIF.PK, DNA, GIS
Even Fatter Yields for Pfizer; M&A Targets in the Sector
on Oct 17, 2008 • ALNY, ALXN, BIIB
Discovery Labs: The Next Biotech Buy?
on Oct 06, 2008 • BMY, BTRX, DNA
Novartis: An Ex-U.S. Proxy for Global Healthcare
on Jul 27, 2008 • ACL, IXJ, JNJ

Articles by Ticker

AA, AAI, AAPL, AAWW, ABBC, ABFS, ABII, ABIO, ABMD, ABT, ABTL, ABV, ABX, ACAD, ACCP.OB, ACEL, ACHN, ACL, ACLI, ACOR, ACTC, ACTC.PK, ACUR, ACUS, ADAM, ADLR, ADLS, ADLS.OB, AET, AEZS, AFFX, AFFY, AFL, AGEN, AGN, AHBIF.PK, AIQ, AIRM, AIS, AKRX, ALEX, ALGT, ALK, ALKS, ALNPY.PK, ALNY, ALO, ALPMF.PK, ALTH, ALV,

Latest Comments on Mike Havrilla's Articles

unblock school on Novartis: An Ex-U.S. Proxy for Global Healthcare: Thanks for great post Mike, Delta more »
drgmoney on Access Pharma Looking for Smooth U.S. MuGard Launch in 2010: Do you know if the post marketing Data on Mugard in Europe will be... more »
jay brebner on EXACT Sciences: Buy and Hold for Long-Term Upside: Thanks Charlie - I didn't know the stats off the top of my head... more »
Super Stock Timer on BioMed News Bytes: Cytori, Questcor: 11-7-09 - BUY DNDN ON THE FIRST CLOSE ABOVE 29.00 - WALTER - SUPER... more »
Charlie L on EXACT Sciences: Buy and Hold for Long-Term Upside: Agree that $300 every 3 years is a bargain compared to a $2,000... more »
jay brebner on EXACT Sciences: Buy and Hold for Long-Term Upside: $300 per test is an absolute bargain to detect CRC early. the... more »
BioGuy on A 130 / 30 Global Pharma Strategy : Good ideas, the generic pharmaceutical market will do well. My... more »
Dr. Bone on A 130 / 30 Global Pharma Strategy : This index sounds very interesting. Is there a way you can... more »
TX Gal 4Evr on Railroad Stocks Steam Ahead on Buffett’s Buy of BNI: Have you not heard of 'change' or 'growth' or 'variety'?? It's... more »
dual cit on Railroad Stocks Steam Ahead on Buffett’s Buy of BNI: Not what I want to hear from you. I have grown accustomed to you... more »
hoopdreamerz@yahoo.com on EXACT Sciences: Patience Required for Long-Term Upside: That's funny they compared their data with OncoMethylone (i had... more »
researchbio48 on Bio-Pharma, Diagnostics Buyout Binge Begins: Hi Mike - not sure how often you upday this link but I was hoping... more »
Mike Havrilla on Unilife: Medical Device Innovator Creating Jobs in Pennsylvania: NEH, The major investment and agreement with Sanofi (SNY) may give... more »
NEH on Unilife: Medical Device Innovator Creating Jobs in Pennsylvania: I love it Mike - it's exactly the kind of under-the-radar... more »
tappy on BioSante Pharma's LibiGel: Big Upside Potential: I have read your comments on Libi-Gel and they are well research... more »

Latest Comments on Mike Havrilla's Articles

Mike Havrilla » Articles » RHHBY.PK |

More on RHHBY.PK by Mike Havrilla

Articles by Ticker

Latest Comments on Mike Havrilla's Articles

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers